Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Juliane Poelchen"'
Autor:
Tamara Steinfass, Juliane Poelchen, Qian Sun, Giovanni Mastrogiulio, Daniel Novak, Marlene Vierthaler, Sandra Pardo, Aniello Federico, Laura Hüser, Thomas Hielscher, Rafael Carretero, Rienk Offringa, Peter Altevogt, Viktor Umansky, Jochen Utikal
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-6 (2023)
Abstract Melanoma is the deadliest form of skin cancer showing rising incidence over the past years. New insights into the mechanisms of melanoma progression contributed to the development of novel treatment options, such as immunotherapies. However,
Externí odkaz:
https://doaj.org/article/415acc4442a0436faeded46a1f470750
Autor:
Alice Pievani, Roberto Savoldelli, Juliane Poelchen, Elisa Mattioli, Giorgio Anselmi, Alice Girardot, Jochen Utikal, Pierre Bourdely, Marta Serafini, Pierre Guermonprez
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Tissue engineering opens multiple opportunities in regenerative medicine, drug testing, and modeling of the hematopoiesis in health and disease. Recapitulating the organization of physiological microenvironments supporting leukocyte development is es
Externí odkaz:
https://doaj.org/article/0f513972e2044522bea853a714f9d80a
Autor:
Marlene Vierthaler, Qian Sun, Yiman Wang, Tamara Steinfass, Juliane Poelchen, Thomas Hielscher, Daniel Novak, Viktor Umansky, Jochen Utikal
Publikováno v:
Cancers, Vol 14, Iss 4, p 1071 (2022)
Background: ADCK2 is a member of the AarF domain-containing kinase family, which consists of five members, and has been shown to play a role in CoQ metabolism. However, ADCKs have also been connected to cancer cell survival, proliferation and motilit
Externí odkaz:
https://doaj.org/article/7299160abc454fd4a611e43652e62608
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 21, p 8274 (2020)
Cellular plasticity of cancer cells is often associated with phenotypic heterogeneity and drug resistance and thus remains a major challenge for the treatment of melanoma and other types of cancer. Melanoma cells have the capacity to switch their phe
Externí odkaz:
https://doaj.org/article/77a04b1921eb4a359aa4e418fa85eebc
Autor:
Qian Sun, Daniel Novak, Laura Hüser, Juliane Poelchen, Huizi Wu, Karol Granados, Aniello Federico Federico, Ke Liu, Tamara Steinfass, Marlene Vierthaler, Viktor Umansky, Jochen Utikal
Publikováno v:
Cancer Research. 83:431-431
Metastatic melanoma is one of the most aggressive skin cancers and is associated with poor prognosis. BRAF and MEK inhibitors are used to treat patients with BRAFV600E-mutated advanced melanoma. However, the development of resistances to these treatm
Autor:
Viktor Umansky, Juliane Poelchen, Jochen Utikal, Karol Granados, Marlene Vierthaler, Laura Hüser, Tamara Steinfass, Qian Sun, Huizi Wu, Ke Liu, Aniello Federico, Daniel Novak
Publikováno v:
International Journal of Cancer. 149:657-674
Metastatic melanoma is an aggressive skin cancer and associated with a poor prognosis. In clinical terms, targeted therapy is one of the most important treatments for patients with BRAFV600E -mutated advanced melanoma. However, the development of res
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 8274, p 8274 (2020)
International Journal of Molecular Sciences, Vol 21, Iss 8274, p 8274 (2020)
Cellular plasticity of cancer cells is often associated with phenotypic heterogeneity and drug resistance and thus remains a major challenge for the treatment of melanoma and other types of cancer. Melanoma cells have the capacity to switch their phe